Drug Interactions Stephen Kravcik MD FRCPC Division of General - - PowerPoint PPT Presentation

drug interactions
SMART_READER_LITE
LIVE PREVIEW

Drug Interactions Stephen Kravcik MD FRCPC Division of General - - PowerPoint PPT Presentation

Drug Interactions Stephen Kravcik MD FRCPC Division of General Medicine University of Ottawa Conflicts of Interest None with pharmaceutical industry Consultant with PHAC CADTH CMPA WSIB Clinical Burden of DDIs


slide-1
SLIDE 1

Drug Interactions

Stephen Kravcik MD FRCPC Division of General Medicine University of Ottawa

slide-2
SLIDE 2

Conflicts of Interest

  • None with pharmaceutical industry
  • Consultant with

– PHAC – CADTH – CMPA – WSIB

slide-3
SLIDE 3

Clinical Burden of DDIs

  • 3-5% of preventable in-hospital adverse

drug reactions

– Majority are unanticipated and unrecognized until after the occurrence

slide-4
SLIDE 4

Two big players

  • P-glycoprotein
slide-5
SLIDE 5
  • Cytochrome P450
slide-6
SLIDE 6

Teaching about DDIs

  • Interesting, if you’re a nerd
  • Pretty dry otherwise
slide-7
SLIDE 7
slide-8
SLIDE 8

DOACs Antibiotics

100 100 100 100 100 100 200 200 200 200 200 200 300 300 300 300 300 300 400 400 400 400 400 400 500 500 500 500 500 500

HIV Meds Warfarin

Miscellaneous

Cool drug AEs

slide-9
SLIDE 9

DOACS 100

A 57yo woman with severe COPD, on chronic azithromycin, develops A fib and requires

  • OAC. With which DOAC are macrolides

safely taken?

slide-10
SLIDE 10

DOACS 100

  • None

– DOAC metabolism is, at least in part, controlled by P-glycoprotein – All macrolides are strong PGP inhibitors – Therefore, macrolide use will increase all DOAC activity, and may lead to an increase in bleeding

Fralick M, Juurlink DN, Marras T. Bleeding associated with coadministration of rivaroxaban and clarithromycin. CMAJ. 2016 Jun 14;188(9):669-72

slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13

DOACS 200

An HIV+ man on Genvoya, which has a strong CYP3A4 inhibitor, is found to have A fib. He has terrible veins and wishes to avoid warfarin use. Which DOAC is safest with a strong inhibitor

  • f CYP450 3A4?
slide-14
SLIDE 14

DOACS 200

– Dabigatran

  • Its is minimally metabolized by any of the cytochromes
  • The other DOACS are significantly metabolized by CYP450,

so inhibitors or inducers of these enzymes will have a significant effect on the effectiveness or safety of DOACs

  • But dabigatran is still not terribly safe with HIV Pis as they

inhibit Pgp

– So best change ARVs or use warfarin

slide-15
SLIDE 15

DOACs 300

Which is least safe with a DOAC when treating a fib: a beta blocker, verapamil or digoxin?

slide-16
SLIDE 16

DOACs 300

  • Verapamil is a strong inhibitor of PGP, and

may lead to an increased risk of bleeding if

  • n a DOAC.
slide-17
SLIDE 17

DOACs 400

Which anticonvulsant is safest with a rivaroxaban or apixaban: phenytoin, carbamazepine or valproic acid?

slide-18
SLIDE 18

DOACs 400

  • Valproic acid

– Phenytoin and carbamazepine are strong inducers of CYP450 3A4 and inducers of PGP, so may dramatically reduce DOAC effectiveness – If these are required, use warfarin: affected by CYP450 but can follow the INR

slide-19
SLIDE 19

DOACs 500

Is amiodarone safe with DOACS?

slide-20
SLIDE 20

DOACs 500

  • Moderate CYP3A4 and mild-mod P-

gp inhibitor

– Dabi levels increase 40% – Use with caution with any DOAC

slide-21
SLIDE 21

Antibiotics 100

  • Which antituberculous drug is the most

potent known CYP450 inducer?

slide-22
SLIDE 22

Antibiotics 100

  • Rifampin
  • Potential substrates:

– All calcium channel blockers – All benzos except for lorazepam, oxazepam and temazepam – Statins (not much with pravastatin) – Estrogens – Apixaban, rivaroxaban, warfarin

slide-23
SLIDE 23

Antibiotics 200 A 65 yo female with dyspepsia, who loves her TUMS, who has not seen a doctor in years, fails treatment of a sensitive gram- UTI with

  • cipro. Why?
slide-24
SLIDE 24

Antibiotics 200

  • Tums and any other di- or tri-valent cations may bind

quinolones and reduce their absorption

– Tums et al should be given at least 2 hours before or 6 hours after a quinolone dose – The same holds for iron, calcium supps and phosphate binders – Do not take with dairy products

  • Also happens with tetracyclines
slide-25
SLIDE 25

Antibiotics 300 A depressed middle aged bodybuilder on citalopram receives linezolid for an MRSA cellulitis. He develops myoclonus and hyperreflexia. Why?

slide-26
SLIDE 26

Antibiotics 300

  • Linezolid use may lead to serotonin syndrome if taken with drugs that

increase serum serotonin levels:

Antidepressants Analgesics SSRIs Tramadol Paroxetine Meperidine Sertraline Methadone Fluoxetine Dextromethorphan Fluvoxamine Dextropropoxyphene Citalopram Pentazocine Escitalopram Antituberculosis SNRIs Isoniazid Venlafaxine Anxiolytics Duloxetine Buspirone Mirtazapine Hypnotics Tricyclic antidepressants l-tryptophan Amitriptyline Migraine Clomipramine Sumatriptan and other triptans Desipramine Stimulants Doxepin Amphetamine and derivatives Imipramine Antineoplastic Nortriptyline Procarbazine Protriptyline Dopamine agonists NRIs Bromocriptine Trazodone Illicit psychotropics Nefazodone Cocaine MAOIs Lysergic acid diethylamide Tranylcypromine Ecstasy Phenelzine Methylenedioxyamphetamine Selegiline N-methyldiethanolamine Herbals 3,4-Methylenedioxymethamphetamine

  • St. John's Wort (Hypericum perforatum)

Ginseng (Panax ginseng)

slide-27
SLIDE 27

Antibiotics 400 A 55 yo male with ALL, on methotrexate, becomes neutropenic when treated for a GAS

  • pharyngitis. Why?
slide-28
SLIDE 28

Antibiotics 400

  • Penicillins block the tubular secretion of methotrexate and

can lead to a significant increase in plasma MTX levels, leading to greater hepatic, renal and bone marrow toxicity

  • f MTX
  • NSAIDs cause renal efferent arteriolar vasoconstriction

and relative renal hypoperfusion. This can lead to MTX bio-accumulation and toxicity.

slide-29
SLIDE 29

Antibiotics 500

What happens when you mix meropenem and valproic acid?

slide-30
SLIDE 30

Antibiotics 500

  • Valproic acid levels plummet

– The nature of the interaction is uncertain – Increasing valproic acid doses will frequently not overcome the reaction and puts the patient at risk of toxicity when the meropenem is stopped

slide-31
SLIDE 31

HIV Meds 100

  • Which two HIV antiretroviral components

are potent P4503A4 inhibitors?

slide-32
SLIDE 32

HIV Meds 100

  • Ritonavir and cobicistat

– Ritonavir in Norvir, Kaletra – Cobicistat in Stribild, Genvoya, Prezcobix

slide-33
SLIDE 33

HIV Meds 100

slide-34
SLIDE 34

HIV Meds 200

  • Which inhaled corticosteroid is safest for

someone on ritonavir

slide-35
SLIDE 35

HIV Meds 200

  • The safest ICS is Qvar (beclomethasone)

– Virtually all other inhaled (oral and nasal) CS are P450-metabolized – Many case reports of hypercortisolism when taken with potent P450 inhibitors

slide-36
SLIDE 36

HIV Meds 300

Which calcium channel blocker is safest in someone taking Genvoya?

slide-37
SLIDE 37

HIV Meds 300

  • None.

– All CCBs are CYP450 3A4 metabolized, and their bioavailability dramatically increased when used with ritonavir (Norvir, Kaletra) or cobicistat (Prezcobix, Stribild, Genvoya)

.

slide-38
SLIDE 38

HIV Meds 400

  • Which is the safest statin with ritonavir?

– Atorvastatin – Simvastatin – Lovastatin – Pravastatin – Rosuvastatin

slide-39
SLIDE 39

HIV Meds 400

  • Which is the safest statin with ritonavir?

– Atorvastatin – limit to 20 mg/day – Simvastatin – DO NOT USE – Lovastatin – DO NOT USE – Pravastatin – no concerns – Rosuvastatin - limit to 10 mg/day

slide-40
SLIDE 40

HIV Meds 500

  • Which of these significantly interacts with

ritonavir/cobicistat?

– Diazepam – Sildenafil – Ergotamine – Ticagrelor

slide-41
SLIDE 41

HIV Meds 500

  • All do

– Diazepam (only safe BDZs are lorazepam, temazepam and oxazepam) – Sildenafil (AUC increases 4x; same with other PDE5 inhibitors) – Ergotamine (absolute CI) – Ticagrelor (AUC increase 7x)

slide-42
SLIDE 42

Warfarin 100

  • Is warfarin pharmacology straightforward?
slide-43
SLIDE 43

. Warfarin 100

  • Not a chance

– Warfarin is a racemic mixture of its R-isomer (less potent) and S-isomer (more potent). S-warfarin is metabolized primarily by the CYP 2C9 isoenzyme whereas R-warfarin is metabolized by CYP 1A2 and 3A4. Depending on the dominant isoenzyme inhibited by the interacting drug, the effect on warfarin may or may not be clinically significant. Consequently, drugs that impact CYP 2C9 metabolism can be expected to have a disproportionate effect on the INR – There are numerous agents, such as metronidazole, trimethoprim/sulfamethoxazole (TMP/SMX), and amiodarone, that are commonly prescribed to older individuals that inhibit the CYP 2C9 pathway These medications, when used in conjunction with warfarin have significant effects on the INR and bleeding risk. In addition, while warfarin clearance is not affected by renal dysfunction, serum levels of interacting drugs (such as ciprofloxacin or TMP/SMX) may increase with renal dysfunction, enhancing the interaction. – Absorption is affected by gut flora, whih is affected by antoibiotics

slide-44
SLIDE 44

Warfarin 200

Is there an oral antibiotic that is free of the potential to alter warfarin absorption or metabolism?

slide-45
SLIDE 45

Warfarin 200

  • No

– Almost all antibiotics can potentiate the effects of warfarin by:

  • Alteration of intestinal flora that produce vitamin K
  • Inhibition or induction of cytochrome P450

– Unless the INR can be monitored every other day, ciprofloxacin, macrolides, metronidazole and TMP-SMX generally should not be prescribed to patients who are taking warfarin

slide-46
SLIDE 46

Warfarin 300 Is acetaminophem safe with warfarin?

slide-47
SLIDE 47

Warfarin 300

  • No

– As few as seven 325-mg tablets of acetaminophen can lead to increased warfarn effect. – The proposed mechanism is the inhibition of CYP450 by acetaminophen resulting in decreased metabolism of warfarin.

slide-48
SLIDE 48

Warfarin 400

Do statins affect warfarin-related anticoagulation?

slide-49
SLIDE 49

Warfarin 400

  • Yes. Statins may inhibit CYP450 metabolism of warfarin

displace warfarin from its binding site on albumin.

  • Unanticipated elevated INR with warfarin has been

reported with concomitant use of fluvastatin, lovastatin, simvastatin and atorvastatin

slide-50
SLIDE 50

Warfarin 500

  • What proportion of patients on warfarin for

atrial fibrillation are taking herbal supps?

slide-51
SLIDE 51

Warfarin 500

  • ~50%
  • In one study of patients prescribed warfarin for chronic atrial

fibrillation patients taking no herbal medications or only 1 herbal < 4 times per week were more likely to have PT-INR values within the

  • ptimal therapeutic range (2.0 to 3.0) compared to those taking > 1

type of herbal ≥ 4 times per week (58.1% vs 51.1%, P = 0.046)

H.T. Chan, L.T. So, S.W. Li, C.W. Siu, C.P. Lau, H.F. Tse. Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial

  • fibrillation. J Cardiovasc Pharmacol, 58 (1) (2011), pp. 87-90

[48]

slide-52
SLIDE 52

Miscellaneous 100

What does grapefruit juice do to drug metabolism?

slide-53
SLIDE 53

Miscellaneous 100

  • A lot:

– Grapefruit contains various furanocoumarins that inhibit CYP3A4, potentially resulting in increases in some drug levels. – Grapefruit also weakly inhibits intestinal cell P-gp, decreasing the efflux of some absorbed drugs back into the gut lumen. – Organic anion transporting polypeptide (OATP) is another transporter system affected by grapefruit. Unlike with CYP3A4 and P-gp, drugs handled by OATP may have decreased absorption when taken with grapefruit, possibly leading to decreased efficacy.

slide-54
SLIDE 54

Miscellaneous 200

What does omeprazole do to clopidogrel?

slide-55
SLIDE 55

Miscellaneous 200

  • It reduces its effectiveness

– Clopidogrel’s anti-platelet activity is entirely the effect of an active metabolite – The active metabolite is formed as the result of clopidogrel metabolism by CYP2C19 – Omeprazole inhibits CYP2C19 activity.

slide-56
SLIDE 56

Miscellaneous 300

How do NSAIDs affect lithium therapy?

slide-57
SLIDE 57

Miscellaneous 300

  • They reduce renal clearance of lithium and therefore may

increase serum levels

– Both NSAIDs and diuretics may lead to increased proximal resorption of lithium – It is recommended that lithium doses be reduced 50% when starting an NSAID or diuretic.

slide-58
SLIDE 58

Miscellaneous 400

Why are nitrates to be used with caution with phosphodiesterase inhibitors?

slide-59
SLIDE 59

Miscellaneous 400

  • Sildafenil and other phosphodiesterase inhibitors potentiate

(double) the effect of nitrates

– All nitrates become NO in vivo – NO promote conversion of GTP to cGMP, which leads to smooth muscle relaxation and venodilation – cGMP is metabolized/inactivated by phosphodiesterase 5; inhibition leads to greater and more prolonged vasodilation, leading to potentially severe hypotension – No nitrates within 24 hours of sildenafil or vardenafil, or within 36 hours of tadalafil

slide-60
SLIDE 60

Miscellaneous 500

Why must tramadol be used with caution in patients taking SSRIs?

slide-61
SLIDE 61

Miscellaneous 500

  • Tramadol exerts its analgesic action through binding of an
  • piate receptor as well as inhibition of SE and NE uptake
  • Concomitant SSRI use has been reported to lead to the

development of serotonin syndrome

slide-62
SLIDE 62

Cool Drug AEs 100

Name four drugs that can cause this:

slide-63
SLIDE 63

Cool Drug AEs 100

  • Pulmonary fibrosis (predominantly lower

lobes)

– Nitrofurantoin – Amiodarone – Methotrexate – Bleomycin – Cyclophosphamide – Numerous other case reports (see Pneumotox website http://www.pneumotox.com/pattern/index/)

slide-64
SLIDE 64

Cool Drug AEs 200

What is this and what caused it?

slide-65
SLIDE 65

Cool Drug AEs 200

  • Flagellate hyperpigmentation from bleomycin

– Prevalence of flagellate hyperpigmentation in those treated with bleomycin may be as high as 20%. – flagellate hyperpigmentation usually fades over a period of several months after the cessation of the medication.

slide-66
SLIDE 66

Cool Drug AEs 300

What is this and what caused it?

slide-67
SLIDE 67
  • HIV lipodystrophy

– Lipoatrophy associated with thymidine analogue nucleoside RTIs like AZT, d4T – Lipohypertrophy less clearly associated with any class; possibly associated with older PIs – Metabolic abnormalities (impaired glucose tolerance, dyslipidemia) associated with fat deposition, fat thinning, AZT, d4T, PIs

Cool Drug AEs 300

slide-68
SLIDE 68

Cool Drug AEs 400

  • What drug?
slide-69
SLIDE 69

Cool Drug AEs 400

  • Blue-grey skin hyperpigmentation from amiodarone

– Occurs in 1-3% of patients on long term low dose amiodarone (150-300 mg/d) – May resolve with lower dose or discontinuation (but may take 1+ year)

slide-70
SLIDE 70

Cool Drug AEs 500

  • She’s bluish but not dyspneic.
slide-71
SLIDE 71

Cool Drug AEs 500

  • Methemoglobinemia
  • Causes:

– sulphonamides – Dapsone – Local anaesthetics – Metocopramide – nitrates

slide-72
SLIDE 72

Things to Remember

  • Look for DDIs:

– When using a DOAC – When using anticonvulsants – When using macrolides – When using amiodarone – When dealing with a patient on meds for HIV – When dealing with a patient on meds for TB

slide-73
SLIDE 73
  • http://www.hiv-druginteractions.org/
  • https://www.drugbank.ca/interax/drug_lookup
  • http://www.umm.edu/health/medical/drug-interaction-tool
slide-74
SLIDE 74

Thank you